Global Prostate Cancer Drugs Market Research Report Forecast 2017-2021

May 2017 | 118 pages | ID: GAFB1AE908CEN
S&P Consulting

Abstracts

The Global Prostate Cancer Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Prostate Cancer Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Prostate Cancer Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Prostate Cancer Drugs Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer

Global Prostate Cancer Drugs Market: Product Segment Analysis
Type 1
Type 2
Type 3


Global Prostate Cancer Drugs Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PROSTATE CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Prostate Cancer Drugs Market Segmentation by Type
  1.2.1 Global Production Market Share of Prostate Cancer Drugs by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Prostate Cancer Drugs Market Segmentation by Application
  1.3.1 Prostate Cancer Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Prostate Cancer Drugs Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Prostate Cancer Drugs (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON PROSTATE CANCER DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL PROSTATE CANCER DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 Global Prostate Cancer Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 Global Prostate Cancer Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Prostate Cancer Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Prostate Cancer Drugs Market Competitive Situation and Trends
  3.5.1 Prostate Cancer Drugs Market Concentration Rate
  3.5.2 Prostate Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL PROSTATE CANCER DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Prostate Cancer Drugs Production by Region (2012-2017)
4.2 Global Prostate Cancer Drugs Production Market Share by Region (2012-2017)
4.3 Global Prostate Cancer Drugs Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL PROSTATE CANCER DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Prostate Cancer Drugs Consumption by Regions (2012-2017)
5.2 North America Prostate Cancer Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Prostate Cancer Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Prostate Cancer Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Prostate Cancer Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Prostate Cancer Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Prostate Cancer Drugs Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL PROSTATE CANCER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Prostate Cancer Drugs Production and Market Share by Type (2012-2017)
6.2 Global Prostate Cancer Drugs Revenue and Market Share by Type (2012-2017)
6.3 Global Prostate Cancer Drugs Price by Type (2012-2017)
6.4 Global Prostate Cancer Drugs Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL PROSTATE CANCER DRUGS MARKET ANALYSIS BY APPLICATION

7.1 Global Prostate Cancer Drugs Consumption and Market Share by Application (2012-2017)
7.2 Global Prostate Cancer Drugs Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL PROSTATE CANCER DRUGS MANUFACTURERS ANALYSIS

8.1 Bristol-Myers Squibb
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 AstraZeneca
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Eli Lilly
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Roche
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 GSK
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Novartis
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Pfizer
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Sanofi
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Bayer
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 PROSTATE CANCER DRUGS MANUFACTURING COST ANALYSIS

9.1 Prostate Cancer Drugs Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Prostate Cancer Drugs

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Prostate Cancer Drugs Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL PROSTATE CANCER DRUGS MARKET FORECAST (2017-2021)

13.1 Global Prostate Cancer Drugs Production, Revenue Forecast (2017-2021)
13.2 Global Prostate Cancer Drugs Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Prostate Cancer Drugs Production Forecast by Type (2017-2021)
13.4 Global Prostate Cancer Drugs Consumption Forecast by Application (2017-2021)
13.5 Prostate Cancer Drugs Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostate Cancer Drugs
Figure Global Production Market Share of Prostate Cancer Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Prostate Cancer Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Prostate Cancer Drugs Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Prostate Cancer Drugs Capacity of Key Manufacturers (2015 and 2016)
Table Global Prostate Cancer Drugs Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Prostate Cancer Drugs Capacity of Key Manufacturers in 2015
Figure Global Prostate Cancer Drugs Capacity of Key Manufacturers in 2016
Table Global Prostate Cancer Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Prostate Cancer Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Prostate Cancer Drugs Production Share by Manufacturers
Figure 2016 Prostate Cancer Drugs Production Share by Manufacturers
Table Global Prostate Cancer Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Prostate Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Prostate Cancer Drugs Revenue Share by Manufacturers
Table 2016 Global Prostate Cancer Drugs Revenue Share by Manufacturers
Table Global Market Prostate Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Prostate Cancer Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Prostate Cancer Drugs Product Type
Figure Prostate Cancer Drugs Market Share of Top 3 Manufacturers
Figure Prostate Cancer Drugs Market Share of Top 5 Manufacturers
Table Global Prostate Cancer Drugs Capacity by Regions (2012-2017)
Figure Global Prostate Cancer Drugs Capacity Market Share by Regions (2012-2017)
Figure Global Prostate Cancer Drugs Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Prostate Cancer Drugs Capacity Market Share by Regions
Table Global Prostate Cancer Drugs Production by Regions (2012-2017)
Figure Global Prostate Cancer Drugs Production and Market Share by Regions (2012-2017)
Figure Global Prostate Cancer Drugs Production Market Share by Regions (2012-2017)
Figure 2015 Global Prostate Cancer Drugs Production Market Share by Regions
Table Global Prostate Cancer Drugs Revenue by Regions (2012-2017)
Table Global Prostate Cancer Drugs Revenue Market Share by Regions (2012-2017)
Table 2015 Global Prostate Cancer Drugs Revenue Market Share by Regions
Table Global Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table China Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table India Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Prostate Cancer Drugs Consumption Market by Regions (2012-2017)
Table Global Prostate Cancer Drugs Consumption Market Share by Regions (2012-2017)
Figure Global Prostate Cancer Drugs Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Prostate Cancer Drugs Consumption Market Share by Regions
Table North America Prostate Cancer Drugs Production, Consumption, Import & Export (2012-2017)
Table Europe Prostate Cancer Drugs Production, Consumption, Import & Export (2012-2017)
Table China Prostate Cancer Drugs Production, Consumption, Import & Export (2012-2017)
Table Japan Prostate Cancer Drugs Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Production, Consumption, Import & Export (2012-2017)
Table India Prostate Cancer Drugs Production, Consumption, Import & Export (2012-2017)
Table Global Prostate Cancer Drugs Production by Type (2012-2017)
Table Global Prostate Cancer Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Prostate Cancer Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Prostate Cancer Drugs by Type
Table Global Prostate Cancer Drugs Revenue by Type (2012-2017)
Table Global Prostate Cancer Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Prostate Cancer Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Prostate Cancer Drugs by Type
Table Global Prostate Cancer Drugs Price by Type (2012-2017)
Figure Global Prostate Cancer Drugs Production Growth by Type (2012-2017)
Table Global Prostate Cancer Drugs Consumption by Application (2012-2017)
Table Global Prostate Cancer Drugs Consumption Market Share by Application (2012-2017)
Figure Global Prostate Cancer Drugs Consumption Market Share by Application in 2015
Table Global Prostate Cancer Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Prostate Cancer Drugs Consumption Growth Rate by Application (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Prostate Cancer Drugs Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Prostate Cancer Drugs Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Prostate Cancer Drugs Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Roche Prostate Cancer Drugs Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GSK Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table GSK Prostate Cancer Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Prostate Cancer Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Prostate Cancer Drugs Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Prostate Cancer Drugs Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Prostate Cancer Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure Global Prostate Cancer Drugs Production and Growth Rate Forecast (2017-2021)
Figure Global Prostate Cancer Drugs Revenue and Growth Rate Forecast (2017-2021)
Table Global Prostate Cancer Drugs Production Forecast by Regions (2017-2021)
Table Global Prostate Cancer Drugs Consumption Forecast by Regions (2017-2021)
Table Global Prostate Cancer Drugs Production Forecast by Type (2017-2021)
Table Global Prostate Cancer Drugs Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer
Celgene